Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of 18F-DCFPyL Positron Emission Tomography (PET) in Men With Intermediate or High Risk Biochemically Recurrent Prostate Cancer

NCT04727736 is registered in ClinicalTrials.gov with Ashok Muthukrishnan as lead sponsor.

NCT NCT04727736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04727736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of 18F-DCFPyL Positron Emission Tomography (PET) in Men With Intermediate or High Risk Biochemically Recurrent Prostate Cancer
Lead sponsor
Ashok Muthukrishnan
Phase
Phase 2
Overall status
Terminated
Start date
May 1, 2021
Completion date
December 31, 2022
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer